ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback